Assignee
GW RES LTD
GB·44 granted patents·72 pending applications·1,259 citations·filing 2013–2024
Top patents by PatentIndex Score
116 records- 0199US10709673B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2019·Granted Jul 14, 2020·48 cites·19 claims
- 0298US11963937B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2023·Granted Apr 23, 2024·14 cites·29 claims
- 0398US11766411B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2022·Granted Sep 26, 2023·17 cites·26 claims
- 0498US11701330B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Jul 18, 2023·19 cites·30 claims
- 0598US11633369B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2022·Granted Apr 25, 2023·26 cites·32 claims
- 0698US11590087B2Cannabidiol-type cannabinoid compoundGW RES LTD·Filed 2022·Granted Feb 28, 2023·23 cites·20 claims
- 0798US11446258B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Sep 20, 2022·30 cites·29 claims
- 0898US11357741B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Jun 14, 2022·33 cites·28 claims
- 0998US11154517B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Oct 26, 2021·38 cites·26 claims
- 1098US11154516B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Oct 26, 2021·42 cites·30 claims
- 1198US11096905B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Aug 24, 2021·43 cites·33 claims
- 1298US10966939B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Granted Apr 6, 2021·47 cites·21 claims
- 1398US10849860B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2018·Granted Dec 1, 2020·49 cites·32 claims
- 1498US10709671B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2016·Granted Jul 14, 2020·52 cites·24 claims
- 1598US10709674B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2019·Granted Jul 14, 2020·50 cites·20 claims
- 1698US10603288B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2018·Granted Mar 31, 2020·49 cites·28 claims
- 1797US11684598B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Jun 27, 2023·17 cites·17 claims
- 1897US11406623B2Methods of treating tuberous sclerosis complex with cannabidiol and everolimusGW RES LTD·Filed 2021·Granted Aug 9, 2022·24 cites·25 claims
- 1997US11400055B2Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Aug 2, 2022·29 cites·17 claims
- 2097US11160795B2Methods of treating tuberous sclerosis complex with cannabidiol and everolimusGW RES LTD·Filed 2021·Granted Nov 2, 2021·38 cites·29 claims
- 2197US11065209B2Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Jul 20, 2021·43 cites·22 claims
- 2297US10918608B2Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2015·Granted Feb 16, 2021·50 cites·25 claims
- 2396US11865102B2Cannabidiol preparations and its usesGW RES LTD·Filed 2021·Granted Jan 9, 2024·18 cites·30 claims
- 2496US11793770B27-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsyGW RES LTD·Filed 2021·Granted Oct 24, 2023·18 cites·12 claims
- 2596US11419829B2Use of cannabidiol in combination with 5-HT2B receptor agonists or amphetamines in the treatment of epilepsyGW RES LTD·Filed 2018·Granted Aug 23, 2022·23 cites·17 claims
- 2696US11229612B2Parenteral formulationsGW RES LTD·Filed 2017·Granted Jan 25, 2022·29 cites·16 claims
- 2796US11207292B2Cannabidiol preparations and its usesGW RES LTD·Filed 2020·Granted Dec 28, 2021·47 cites·26 claims
- 2896US11147783B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2016·Granted Oct 19, 2021·30 cites·19 claims
- 2996US11147776B27-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsyGW RES LTD·Filed 2019·Granted Oct 19, 2021·33 cites·21 claims
- 3096US10583096B2Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2017·Granted Mar 10, 2020·35 cites·19 claims
- 3195US11679087B2Use of cannabinoids in the treatment of Angelman syndromeGW RES LTD·Filed 2017·Granted Jun 20, 2023·18 cites·19 claims
- 3294US11426362B2Oral cannabinoid formulationsGW RES LTD·Filed 2018·Granted Aug 30, 2022·27 cites·35 claims
- 3394US11065227B2Use of cannabinoids in the treatment of multiple myelomaGW RES LTD·Filed 2017·Granted Jul 20, 2021·38 cites·16 claims
- 3493US11291631B2Oral cannabinoid formulationsGW RES LTD·Filed 2017·Granted Apr 5, 2022·25 cites·20 claims
- 3593US11160757B1pH dependent release coated microparticle cannabinoid formulationsGW RES LTD·Filed 2020·Granted Nov 2, 2021·36 cites·30 claims
- 3693US11000486B2Combination of cannabinoids in the treatment of leukaemiaGW RES LTD·Filed 2018·Granted May 11, 2021·16 cites·18 claims
- 3792US10098867B2Use of phytocannabinoids in the treatment of ovarian carcinomaGW RES LTD·Filed 2014·Granted Oct 16, 2018·39 cites·3 claims
- 3891US2024165048A1Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2023·Application pending·0 cites
- 3990US10226433B2Use of cannabinoids in the treatment of degenerative skeletal muscle diseasesGW RES LTD·Filed 2015·Granted Mar 12, 2019·15 cites·4 claims
- 4089US11806319B2Pharmaceutical composition comprising a cannabinoidGW RES LTD·Filed 2019·Granted Nov 7, 2023·16 cites·18 claims
- 4184US10220005B2Synergistic therapies of cannabidiol with hypothermia for neuroprotectionGW RES LTD·Filed 2013·Granted Mar 5, 2019·15 cites·3 claims
- 4284US2022202738A1Cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2022·Application pending·0 cites
- 4380US2024261234A1Use of cannabidiol in the treatment of nocturnal snoringGW RES LTD·Filed 2023·Application pending·0 cites
- 4479US2024207220A1Cannabidiol preparations and its usesGW RES LTD·Filed 2023·Application pending·0 cites
- 4578US2024033229A1Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2023·Application pending·0 cites
- 4678US2022323375A1Use of cannabidiol in the treatment of epilepsyGW RES LTD·Filed 2022·Application pending·0 cites
- 4777US2020368179A1Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Application pending·0 cites
- 4877US2025177321A1Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2024·Application pending·0 cites
- 4975US2020179303A1Use of cannabinoids in the treatment of epilepsyGW RES LTD·Filed 2020·Application pending·0 cites
- 5073US2023032502A1Use of cannabidiol in the treatment of nocturnal snoringGW RES LTD·Filed 2022·Application pending·0 cites
Showing the top 50 of 116 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when GW RES LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →